Article Details
Retrieved on: 2024-11-15 16:49:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Arbutus Biopharma (ABUS) has released an update. Arbutus Biopharma has reported that their RNAi therapeutic candidate, imdusiran, combined with a ...
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here